240 related articles for article (PubMed ID: 23029570)
1. Determining treatment needs at different spatial scales using geostatistical model-based risk estimates of schistosomiasis.
Schur N; Vounatsou P; Utzinger J
PLoS Negl Trop Dis; 2012; 6(9):e1773. PubMed ID: 23029570
[TBL] [Abstract][Full Text] [Related]
2. Spatial distribution of schistosomiasis and treatment needs in sub-Saharan Africa: a systematic review and geostatistical analysis.
Lai YS; Biedermann P; Ekpo UF; Garba A; Mathieu E; Midzi N; Mwinzi P; N'Goran EK; Raso G; Assaré RK; Sacko M; Schur N; Talla I; Tchuenté LA; Touré S; Winkler MS; Utzinger J; Vounatsou P
Lancet Infect Dis; 2015 Aug; 15(8):927-40. PubMed ID: 26004859
[TBL] [Abstract][Full Text] [Related]
3. Schistosomiasis control in Senegal: results from community data analysis for optimizing preventive chemotherapy intervention with praziquantel.
Diop B; Sylla K; Kane NM; Boh OK; Guèye B; Ba M; Talla I; Mané M; Monteil R; Kinvi B; Zoure HGM; Ortega JC; Mwinzi P; Sacko M; Faye B
Infect Dis Poverty; 2023 Nov; 12(1):106. PubMed ID: 38008772
[TBL] [Abstract][Full Text] [Related]
4. Assessment of global guidelines for preventive chemotherapy against schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling study.
Lo NC; Lai YS; Karagiannis-Voules DA; Bogoch II; Coulibaly JT; Bendavid E; Utzinger J; Vounatsou P; Andrews JR
Lancet Infect Dis; 2016 Sep; 16(9):1065-1075. PubMed ID: 27286968
[TBL] [Abstract][Full Text] [Related]
5. Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: a spatiotemporal modelling study.
Kokaliaris C; Garba A; Matuska M; Bronzan RN; Colley DG; Dorkenoo AM; Ekpo UF; Fleming FM; French MD; Kabore A; Mbonigaba JB; Midzi N; Mwinzi PNM; N'Goran EK; Polo MR; Sacko M; Tchuem Tchuenté LA; Tukahebwa EM; Uvon PA; Yang G; Wiesner L; Zhang Y; Utzinger J; Vounatsou P
Lancet Infect Dis; 2022 Jan; 22(1):136-149. PubMed ID: 34863336
[TBL] [Abstract][Full Text] [Related]
6. Optimising cluster survey design for planning schistosomiasis preventive chemotherapy.
Knowles SCL; Sturrock HJW; Turner H; Whitton JM; Gower CM; Jemu S; Phillips AE; Meite A; Thomas B; Kollie K; Thomas C; Rebollo MP; Styles B; Clements M; Fenwick A; Harrison WE; Fleming FM
PLoS Negl Trop Dis; 2017 May; 11(5):e0005599. PubMed ID: 28552961
[TBL] [Abstract][Full Text] [Related]
7. Combined spatial prediction of schistosomiasis and soil-transmitted helminthiasis in Sierra Leone: a tool for integrated disease control.
Hodges MH; Soares Magalhães RJ; Paye J; Koroma JB; Sonnie M; Clements A; Zhang Y
PLoS Negl Trop Dis; 2012; 6(6):e1694. PubMed ID: 22724034
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of school-based preventive chemotherapy strategies for sustaining the control of schistosomiasis in Côte d'Ivoire: Results of a 5-year cluster randomized trial.
Ouattara M; Diakité NR; Yao PK; Saric J; Coulibaly JT; Assaré RK; Bassa FK; Koné N; Guindo-Coulibaly N; Hattendorf J; Utzinger J; N'Goran EK
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008845. PubMed ID: 33449924
[TBL] [Abstract][Full Text] [Related]
9. Towards control of schistosomiasis in sub-Saharan Africa.
Southgate VR; Rollinson D; Tchuem Tchuenté LA; Hagan P
J Helminthol; 2005 Sep; 79(3):181-5. PubMed ID: 16153310
[TBL] [Abstract][Full Text] [Related]
10. Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.
Phillips AE; Gazzinelli-Guimaraes PH; Aurelio HO; Ferro J; Nala R; Clements M; King CH; Fenwick A; Fleming FM; Dhanani N
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006061. PubMed ID: 29220347
[TBL] [Abstract][Full Text] [Related]
11. Evaluating survey designs for targeting preventive chemotherapy against Schistosoma haematobium and Schistosoma mansoni across sub-Saharan Africa: a geostatistical analysis and modelling study.
Fornace KM; Fronterrè C; Fleming FM; Simpson H; Zoure H; Rebollo M; Mwinzi P; Vounatsou P; Pullan RL
Parasit Vectors; 2020 Nov; 13(1):555. PubMed ID: 33203463
[TBL] [Abstract][Full Text] [Related]
12. Geostatistical model-based estimates of Schistosomiasis prevalence among individuals aged ≤ 20 years in West Africa.
Schur N; Hürlimann E; Garba A; Traoré MS; Ndir O; Ratard RC; Tchuem Tchuenté LA; Kristensen TK; Utzinger J; Vounatsou P
PLoS Negl Trop Dis; 2011 Jun; 5(6):e1194. PubMed ID: 21695107
[TBL] [Abstract][Full Text] [Related]
13. Schistosomiasis: number of people receiving preventive chemotherapy in 2012.
Wkly Epidemiol Rec; 2014 Jan; 89(2):21-8. PubMed ID: 24446558
[No Abstract] [Full Text] [Related]
14. Advocacy, policies and practicalities of preventive chemotherapy campaigns for African children with schistosomiasis.
Stothard JR; Sousa-Figueiredo JC; Navaratnam AM
Expert Rev Anti Infect Ther; 2013 Jul; 11(7):733-52. PubMed ID: 23879611
[TBL] [Abstract][Full Text] [Related]
15. Can direct smear results that are routinely collected at health centre level be used for monitoring the impact of mass drug administration with praziquantel on schistosomiasis in Burundi? A preliminary assessment.
Bizimana P; Polman K; Ortu G; Krit M; Nsabiyumva F; Nkeshimana A; Bijabuka U; Nibakire M; Van Geertruyden JP
Parasit Vectors; 2020 Apr; 13(1):206. PubMed ID: 32317007
[TBL] [Abstract][Full Text] [Related]
16. Spatially explicit Schistosoma infection risk in eastern Africa using Bayesian geostatistical modelling.
Schur N; Hürlimann E; Stensgaard AS; Chimfwembe K; Mushinge G; Simoonga C; Kabatereine NB; Kristensen TK; Utzinger J; Vounatsou P
Acta Trop; 2013 Nov; 128(2):365-77. PubMed ID: 22019933
[TBL] [Abstract][Full Text] [Related]
17. Review of 2022 WHO guidelines on the control and elimination of schistosomiasis.
Lo NC; Bezerra FSM; Colley DG; Fleming FM; Homeida M; Kabatereine N; Kabole FM; King CH; Mafe MA; Midzi N; Mutapi F; Mwanga JR; Ramzy RMR; Satrija F; Stothard JR; Traoré MS; Webster JP; Utzinger J; Zhou XN; Danso-Appiah A; Eusebi P; Loker ES; Obonyo CO; Quansah R; Liang S; Vaillant M; Murad MH; Hagan P; Garba A
Lancet Infect Dis; 2022 Nov; 22(11):e327-e335. PubMed ID: 35594896
[TBL] [Abstract][Full Text] [Related]
18. Putting the treatment of paediatric schistosomiasis into context.
Mduluza T; Mutapi F
Infect Dis Poverty; 2017 Apr; 6(1):85. PubMed ID: 28388940
[TBL] [Abstract][Full Text] [Related]
19. Praziquantel-related visual disorders among recipients in mass drug administration campaigns in schistosomiasis endemic settings: Systematic review and meta-analysis protocol.
Danso-Appiah A; Owiredu D; Akuffo KO
PLoS One; 2024; 19(5):e0300384. PubMed ID: 38758736
[TBL] [Abstract][Full Text] [Related]
20. Profiling Nonrecipients of Mass Drug Administration for Schistosomiasis and Hookworm Infections: A Comprehensive Analysis of Praziquantel and Albendazole Coverage in Community-Directed Treatment in Uganda.
Chami GF; Kontoleon AA; Bulte E; Fenwick A; Kabatereine NB; Tukahebwa EM; Dunne DW
Clin Infect Dis; 2016 Jan; 62(2):200-7. PubMed ID: 26409064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
